Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT01287182
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT01287182
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Lebanon
- Registry status
- Completed
Technical summary
Registry record NCT01287182. Non-randomized; no masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2011-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
- Condition
- Atherosclerosis
- Intervention (Drug)
- Ateronon
- Lead sponsor
- Omicron Pharmaceuticals
Record details
- Record id
cardio:ct-nct01287182- Content hash
33b98899c0ba41a183a223ec7687647baad7983f432d0a30d1b8c8115d36ade5